Navigation Links


MabThera in Medical News

Growth Opportunities for Actemra Will Propel Roche to Sixth Position in the Rheumatoid Arthritis Market by 2012

...h other mechanisms of action, such as Orencia and Biogen Idec/Genentech's Rituxan (also marketed by Chugai and Zenyaku Kogyo in Japan, and marketed as mabthera in Europe by Roche), largely for TNF-alpha inadequate responders. According to the new report entitled Brands & Strategies : Rheumatoid Arthriti...
MabThera in Medical Technology

Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma

Adding MabThera to first line chemotherapy significantly increases patients_ overall survival BASEL, Switzerland (21 May, 2007) _ In a study published yesterday in the Journal of Clinical Oncology, MabThera (rituximab) plus chemotherapy (MCP*) was shown to significantly improve survival in patie...

Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology

...e response following first-line treatment with CVP chemotherapy. Genentech and Biogen Idec co-market Rituxan in the United States, and Roche markets mabthera in the rest of the world, except Japan, where Rituxan is co-marketed by Chugai and Zenyaku Kogyo Co. Ltd. Rituxan has more than 1,000,000 patient expo...

Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology

...e response following first-line treatment with CVP chemotherapy. Genentech and Biogen Idec co-market Rituxan in the United States, and Roche markets mabthera in the rest of the world, except Japan, where Rituxan is co-marketed by Chugai and Zenyaku Kogyo Co. Ltd. Rituxan has more than 1,000,000 patient expo...

MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen

...ional Cancer Institute, the innovative cancer drug mabthera was shown to improve overall survival in patients ...relapsed patients involved in trials that compared mabthera treatment regimens with chemotherapy alone. The re...with MabThera but also that disease control in the mabthera containing arms of the trials was significantly su...

MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone

... that over half (53%) of the patients treated with mabthera were still alive after seven years compared with j...bThera. The analysis also demonstrated that more mabthera treated patients were in remission at seven years ...is study clearly demonstrates that the addition of mabthera to treatment cures more patients with aggressive l...

New Data Confirms Significant Improvement of Disease Signs and Symptoms in Patients with Rheumatoid Arthritis

...g the launch of MabThera® (rituximab) there are a number of projects in development, potentially allowing Roche to build on further opportunities. mabthera is the first and only selective B-cell therapy for RA, providing a fundamentally different treatment approach by targeting B cells, one of the key pla...
Other TagsPOLYSORBENDOLOOP
(Date:11/26/2009)...er thrill when on an emotional rollercoaster, stud... News) -- Call it the fear factor meets the jubila...tators -- especially those who root for the winnin...a closely contested match and victory was in doubt..., Chew on that this Thanksgiving weekend as you,r...
(Date:11/26/2009)... Benton Communications announces a highl...tem for retailers struggling to make an economic r...er 26, 2009 -- Flu fears is the type of challenge ...ncy room, according to Dr. David Benton, business ...iness growth system – The Rfactor Intensive...
(Date:11/25/2009)...LLE,Calif.,Nov.25/PRNewswire-FirstCall/-- OnyxPha...thecompanywillhosttwoinvestoreventsinDecember: ,...CT/10:00a.m.ET ,, Principalinvestigatorswilld...apsedand/orrefractorymultiplemyeloma,asfeaturedatt...gandExpositioninNewOrleans,LA.Theteleconferencewil...
(Date:11/25/2009)...PRING,Md.,Nov.25/PRNewswire-USNewswire/--Anarticle...ugEvaluationandResearch,titled"ADifficultBalance-P...v.26,2009issueofTheNewEnglandJournalofMedicine. ,...90824/FDALOGO ) ,, Inthearticle,Woodcockdiscuss...icationforthosewhoneeditandmanagingtherisksposedby...
(Date:11/25/2009)...vivors of testicular cancer who were treated with ...effects, including neurological side effects and R...ed with chemotherapy, according to a new study pub...ational Cancer Institute . , Marianne Brydy, M.D...sity Hospital, in Bergen, Norway, and colleagues c...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
(Date:11/24/2009)... 24, 2009) -- The Wildlife Conservation Society (W...st remaining population of Siberian tigers has lik...of poaching and habitat loss. , WCS ... of what needs to be done to protect remaining pop... The report was released by the Siberian Tiger ...
(Date:11/23/2009)...rong evidence that the "synergistic" effect of ear...ollution and indoor endotoxin causes more harm to ...one. , Environmental health scientists at the ...have shown that children exposed to both high leve...in during early life are six times more likely to ...
(Date:11/23/2009)...rticipants gathered this week for the seventh annu...erence. This year,s topic, "Synthetic Biology," br...researchers to explore the engineering, scientific... of synthetic biology. , Bonnie L. Bassler, prof... and this year,s conference chair, challenged the ...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Haemonetics Signs Comprehensive Agreement with Blood Centers of America 57334 1Haemonetics Signs Comprehensive Agreement with Blood Centers of America 57334 2Cynosure Names Paul Cardarelli Vice President of Business Development 57332 1Cynosure Names Paul Cardarelli Vice President of Business Development 57332 2Cynosure Names Paul Cardarelli Vice President of Business Development 57332 3Cynosure Names Paul Cardarelli Vice President of Business Development 57332 4Pesticides Linked to Parkinsons 57331 1Pesticides Linked to Parkinsons 57331 2
Other Contentsanesthesiologyanestheticanestheticanestheticpectorisangioplastyangioplastyangioplastyangioplastyangioplastyanhidrosisanomalyanomalyanomalyankleankleankleankylosingankylosingankylosing